SCHEMBL29417566

SCHEMBL29417566

Nc1ccnc(C(=O)N2CCOCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ RAB9A P51151 10/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ PIK3C3 Q8NEB9 1/20 0.47
▸ NPC1 O15118 9/20 0.47
▸ TP53 P04637 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ LRRK2 Q5S007 1/20 0.46
▸ HPGD P15428 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NTRK1 P04629 1/20 0.45
▸ PLK4 O00444 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ TDO2 P48775 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3439414 0.82 RAB9A (0.56) SMN1; SMN2RAB9AALDH1A1CYP1A2NPC1
SCHEMBL15223500 0.82 RAB9A (0.56) SMN1; SMN2RAB9AALDH1A1CYP1A2NPC1
SCHEMBL3401608 0.82 HRH4 (0.50) SMN1; SMN2RAB9AALDH1A1PIK3C3NPC1
SCHEMBL3396331 0.81 EPHX2 (0.41) SMN1; SMN2PIK3C3
SCHEMBL28296111 0.79 ALDH1A1 (0.52) SMN1; SMN2RAB9AALDH1A1CYP1A2NPC1
SCHEMBL3875051 0.79 SMN1; SMN2 (0.56) SMN1; SMN2RAB9AALDH1A1CYP1A2HPGD
SCHEMBL3186273 0.78 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AALDH1A1CYP1A2PIK3C3
SCHEMBL11918962 0.78 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AALDH1A1CYP1A2NPC1
SCHEMBL28045432 0.77 SMN1; SMN2 (0.48) SMN1; SMN2RAB9AALDH1A1CYP1A2PIK3C3
SCHEMBL3227298 0.77 SMN1; SMN2 (0.70) SMN1; SMN2RAB9AALDH1A1CYP1A2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053022-A1 METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 赛诺哈勃药业(成都)有限公司 2022-03-17 — — WO disclosed
Send feedback